[1] Peng XH, Karna P, O'Regan RM,et al. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol. 2007;71(1): 101-111.[2] Nair AS, Shishodia S, Ahn KS,et al. Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion.J Immunol. 2006;177(8):5612-5622.[3] Murillo G, Peng X, Torres KE,et al. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway.Cancer Prev Res (Phila). 2009;2(11):942-950.[4] Kimmel CB, Ballard WW, Kimmel SR,et al. Stages of embryonic development of the zebrafish.Dev Dyn. 1995; 203(3): 253-310.[5] Cadigan KM, Nusse R.Wnt signaling: a common theme in animal development. Genes Dev. 1997;11(24):3286-3305.[6] Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways.Science. 2004;303(5663):1483-1487.[7] Stemmer V, de Craene B, Berx G,et al. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene. 2008;27(37):5075-5080.[8] Seo J, Asaoka Y, Nagai Y,et al. Negative regulation of wnt11 expression by Jnk signaling during zebrafish gastrulation. J Cell Biochem. 2010;110(4):1022-1037. |